Manufacturers Life Insurance Company, The Pardes Biosciences, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$2.14 - $3.7 $60,119 - $103,944	-28,093 Reduced 38.93%	44,071 $95,000
Q3 2022 Nov 03, 2022	SELL	$2.14 - $3.7 $60,119 - $103,944	-28,093 Reduced 38.93%	44,071 $88,000
Q2 2022 Aug 11, 2023	SELL	$2.84 - $8.57 $28,147 - $84,937	-9,911 Reduced 12.08%	72,164 $221,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $8.57 $28,147 - $84,937	-9,911 Reduced 12.08%	72,164 $217,000
Q1 2022 Aug 11, 2023	BUY	$5.64 - $15.64 $462,903 - $1.28 Million	82,075 New	82,075 $592,000
Q1 2022 May 20, 2022	BUY	$5.64 - $15.64 $462,903 - $1.28 Million	82,075 New	82,075 $613,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.